Literature DB >> 9602595

Intraperitoneal bupivacaine or lidocaine does not provide analgesia after total abdominal hysterectomy.

P B Ali1, B R Cotton, K M Williamson, G Smith.   

Abstract

We have compared pain scores at rest and on standardized movement, and morphine consumption using patient-controlled analgesia in 60 patients who had undergone total abdominal hysterectomy. Patients were allocated randomly to one of three groups: in the saline group, 0.9% sodium chloride 50 ml was administered into the pelvic cavity before closure of the peritoneum; in the second group, the solution administered was 20 ml of 0.5% bupivacaine solution with epinephrine 1:200,000 diluted with saline to a final volume of 50 ml; in the third group, the solution used was 20 ml [corrected] of 2% lidocaine with epinephrine 1:200,000 diluted with saline to a final volume of 50 ml. We found that there was no significant difference between the three groups in visual analogue pain scores at 8, 12, 36 or 48 h after operation at rest or on movement, and no significant difference in sedation or dose of antiemetic administered. Mean morphine consumption in the first 24 h was 54.6 (SEM 5.9) mg in the saline group, 55.5 (6.4) mg in the bupivacaine group and 52.5 (5.3) mg in the lidocaine group. In the second 24 h, morphine consumption was 34.9 (6.6) mg, 28.1 (3.5) mg and 28.0 (3.5) mg in the three groups, respectively. We conclude that i.p. administration of local anaesthetic solution into the pelvic cavity did not confer appreciable analgesia in patients undergoing abdominal hysterectomy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9602595     DOI: 10.1093/bja/80.2.245

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  7 in total

Review 1.  Drug interactions with patient-controlled analgesia.

Authors:  Jorn Lotsch; Carsten Skarke; Irmgard Tegeder; Gerd Geisslinger
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Comparison of Topical and Subcutaneous Bupivacaine Infiltration with Subcutaneous Ketamine on Postoperative Pain in Total Abdominal Hysterectomy.

Authors:  Maryam Maktabi; Alireza Kamali; Hamede Taghavi Jelodar; Maryam Shokrpour
Journal:  Med Arch       Date:  2019-02

3.  Application of Negative Pressure Wound Therapy with Instillation and Dwell Time of the Open Abdomen: Initial Experience.

Authors:  Luis G Fernandez; Pablo Sibaja Alvarez; Mark J Kaplan; Alfredo A Sanchez-Betancourt; Marc R Matthews; Alan Cook
Journal:  Cureus       Date:  2019-09-16

4.  Cost evaluation of temporary abdominal closure methods in abdominal sepsis patients successfully treated with an open abdomen. Should we take temporary abdominal closure methods at face value? Health economic evaluation.

Authors:  Alfredo Sanchez Betancourt; Gonzalez Cole Milagros; Pablo Sibaja; Luis Fernandez; Scott Norwood
Journal:  Ann Med Surg (Lond)       Date:  2020-06-09

5.  Intravenous Clonidine versus Intraperitoneal Clonidine for Postoperative Analgesia After Total Abdominal Hysterectomy: A Randomised Controlled Trial.

Authors:  Divya Gupta; Pramod Mangwana; Roma Sharma; Bharti Wadhwa; Sukhyanti Kerai
Journal:  Turk J Anaesthesiol Reanim       Date:  2020-11-30

6.  The pharmacokinetics and safety of an intraoperative bupivacaine-collagen implant (XaraColl(®)) for postoperative analgesia in women following total abdominal hysterectomy.

Authors:  Susan L Cusack; Philip Reginald; Lisa Hemsen; Emmanuel Umerah
Journal:  J Pain Res       Date:  2013-03-04       Impact factor: 3.133

7.  Comparison Between Intraperitoneal and Intravenous Lidocaine for Postoperative Analgesia After Elective Abdominal Hysterectomy, a Double-Blind Placebo Controlled Study.

Authors:  Saghar Samimi; Arman Taheri; Fatemeh Davari Tanha
Journal:  J Family Reprod Health       Date:  2015-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.